Josh Mandel-Brehm - 15 Oct 2024 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role: Chief Executive Officer, Director
Signature: By: /s/ Thomas Danielski, Attorney-in-Fact
Issuer symbol: CAMP
Transactions as of: 15 Oct 2024
Net transactions value: $0
Form type: 4
Filing time: 15 Oct 2024, 17:45:11 UTC
Previous filing: 10 Oct 2024
Next filing: 03 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CAMP	Common Stock	Conversion of derivative security		+605	+0.22%		272,357	15 Oct 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CAMP	Series B Preferred Stock	Conversion of derivative security		-6,791	-100%		0	15 Oct 2024	Common Stock	605		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering.